"They took me away from everything that helped me to get and stay sober," Bryan Getchius, who was honoring long-term sobriety at the time of his arrest, told reporters on Wednesday.

The FDA narrowed leucovorin's use to a rare disorder, a major shift after Trump and RFK Jr. promoted it for autism.

The FDA has faced an extraordinary convergence of political, scientific, legal, and operational pressures over the last year.

An Immigration and Customs Enforcement detainee was repeatedly denied his antipsychotic medication, resulting in cascading symptoms that caused him to harm himself and end up blind from one eye, a ...

For full-year 2025, 58 biotech deals worth $65.9 billion were completed compared with 73 deals worth $109 billion in all of 2024. This represents a major decline in total dollar volume and the number ...

Stormont’s health minister has been urged to give “clear answers” on whether Northern Ireland will follow an NHS England ban on opposite-sex hormones being prescribed to teenagers – amid concerns ...

A Boynton Beach man has filed a federal civil rights lawsuit against a South Carolina county and sheriff’s department after ...

A pathology expert has described the case of missing Belfast schoolboy Noah Donohoe as "one of the most extraordinary cases" he has dealt with. Dr Nathaniel Cary, a home office-registered consultant ...

Cannabis and other illicit drugs are associated with higher stroke risk, underscoring the importance of addressing substance ...

WASHINGTON (AP) — The Food and Drug Administration on Tuesday approved a generic medication for a rare brain disorder, while walking back statements by President Donald Trump and other administration ...

Ixekizumab demonstrates strong response rates in juvenile arthritis. Read more about the latest trial findings.

Eli Lilly is infusing $3 billion into its manufacturing operations in China, pledging to set up local production and supply for oral solid drugs as it works on building out capacity for its experim | ...